Histopathological Changes in Lesional and Perilesional Vitiligo Skin
暂无分享,去创建一个
[1] P. Rousselle,et al. The Human Epidermal Basement Membrane: A Shaped and Cell Instructive Platform That Aging Slowly Alters , 2020, Biomolecules.
[2] Vivek Gupta,et al. Clinical and Histopathological Study in Vitiligo Patients , 2019, journal of Medical Science And clinical Research.
[3] H. Gamil,et al. Histopathological Findings in Lesional and Perilesional Skin of Vitiligo Patients Before and After Narrow Band Ultraviolet B Phototherapy , 2019, Zagazig University Medical Journal.
[4] Vivek T. Natarajan,et al. Mapping architectural and transcriptional alterations in non-lesional and lesional epidermis in vitiligo , 2017, Scientific Reports.
[5] N. van Geel,et al. Vitiligo: An Update on Pathophysiology and Treatment Options , 2017, American Journal of Clinical Dermatology.
[6] G. Mohammed,et al. Highlights in pathogenesis of vitiligo. , 2015, World journal of clinical cases.
[7] E. S. Hewedy,et al. Clinical and ultrastructural study of nevus depigmentosus , 2013 .
[8] K. Schallreuter,et al. A review of the worldwide prevalence of vitiligo in children/adolescents and adults , 2012, International journal of dermatology.
[9] A. Abdou,et al. Immunolocalization of Tenascin-C in Vitiligo , 2012, Applied immunohistochemistry & molecular morphology : AIMM.
[10] M. Picardo,et al. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference , 2012, Pigment cell & melanoma research.
[11] Aroni Kyriaki,et al. Correlating epidermal thickness and basement membrane length to angiogenesis in the centre and the periphery of vitiligo lesion. , 2012, Indian journal of dermatology, venereology and leprology.
[12] Meaghan Daly,et al. Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. , 2011, Journal of the American Academy of Dermatology.
[13] S. Glassman. Vitiligo, reactive oxygen species and T-cells. , 2011, Clinical science.
[14] R. Clark,et al. First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi , 2010, Pigment cell & melanoma research.
[15] E. Patsouris,et al. Increased angiogenesis and mast cells in the centre compared to the periphery of vitiligo lesions , 2010, Archives of Dermatological Research.
[16] Eun-So Lee,et al. Histopathologic Features in Vitiligo , 2008, The American Journal of dermatopathology.
[17] C. Assaf,et al. Sequential immunohistochemical study of depigmenting and repigmenting minigrafts in vitiligo. , 2003, European journal of dermatology : EJD.
[18] M. Abdel-Aty,et al. Prevalence of skin diseases in rural areas of Assiut Governorate, Upper Egypt , 2003, International journal of dermatology.
[19] D. Tobin,et al. Melanocytes are not absent in lesional skin of long duration vitiligo. , 2000, The Journal of pathology.
[20] D. Bartosik,et al. Molecular and functional analysis of pTAV320, a repABC-type replicon of the Paracoccus versutus composite plasmid pTAV1. , 1998, Microbiology.
[21] H. Wulf,et al. Photoprotection in vitiligo and normal skin. A quantitative assessment of the role of stratum corneum, viable epidermis and pigmentation. , 1996, Acta dermato-venereologica.
[22] W. Westerhof,et al. Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. , 1993, The Journal of investigative dermatology.
[23] J. Ortonne,et al. Vitiligo: where do we stand? , 1993, Pigment cell research.
[24] R. Misra,et al. Neural differentiation of melanocytes in vitiliginous skin. , 1988, Acta Anatomica.